Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone

Basic information Safety Supplier Related

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone Basic information

Product Name:
1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone
Synonyms:
  • 1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone
  • 1-(DiphenylMethyl)-4-(1-oxo-3,3-diphenylpropyl)piperazine
  • 39-1B4
  • NP 118809
  • Z160
  • Piperazine, 1-(diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)-
  • 39-1B4; NP-118809
  • NP 118809;NP118809
CAS:
41332-24-5
MF:
C32H32N2O
MW:
460.61
Product Categories:
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
41332-24-5.mol
More
Less

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone Chemical Properties

Boiling point:
618.9±55.0 °C(Predicted)
Density 
1.142±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
solubility 
DMSO : 50 mg/mL (108.55 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
form 
Powder
pka
5.99±0.10(Predicted)
color 
Light yellow to yellow
More
Less

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone Usage And Synthesis

Uses

An analog of Cinnarizine (C465300), a calcium channel blocker as anti-inflammatory agent.

Synthesis

606-83-7

841-77-0

41332-24-5

Procedure for the synthesis of 1-(Diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)piperazine: to an anhydrous dichloromethane (40 mL) solution of 1-(Diphenylmethyl)piperazine (2.08 mmol), under nitrogen protection, was added 3,3 -diphenylpropionic acid (0.472 g, 2.08 mmol). Subsequently, EDC (0.797 g, 4.16 mmol) and a catalytic amount of DMAP were added to the reaction mixture, which was stirred overnight at room temperature under nitrogen atmosphere. After completion of the reaction, the mixture was concentrated under reduced pressure. The residue was dissolved in a solvent mixture of ethyl acetate and water (10:1, 150 mL). The organic phase was washed sequentially with water (30 mL, twice) and 10% NaOH solution (30 mL), dried with anhydrous magnesium sulfate and evaporated under reduced pressure to remove the solvent. The crude product obtained was purified by column chromatography with the eluent being a mixture of petroleum ether and ethyl acetate (3:1), and the target product 1-(diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)piperazine was finally obtained in 78% yield.

in vivo

NP118809 (25 mg/kg, i.p.) shows significant analgesic activity in the phase IIA portions of the rat formalin model[1]. NP118809 (30 mg/kg, p.o.) results in 80.3% inhibition of mechanical allodynia and 96.3% inhibition of thermal hyperalgesia in the rat spinal nerve ligation model[2].

IC 50

N-type calcium channel: 0.11 μM (IC50); L-type calcium channel: 12.2 μM (IC50)

References

[1] Patent: US2004/259866, 2004, A1
[2] Patent: US6951862, 2005, B2
[3] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 22, p. 6467 - 6472
[4] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 4, p. 1378 - 1383

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanoneSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Email
info@chemexpress.com
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 13167063860
Email
anhua.mao@aladdin-e.com
Xinyanhe Pharmatech Co.,Ltd
Tel
0519-85252752 15366845260
Email
taihuaren@vip.163.com
More
Less

1-[4-(DiphenylMethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone(41332-24-5)Related Product Information